ipilimumab
bms
[' ipi ', 'melanoma', 'congrat']
first randomized study to show til improves pfs vs ipi in advanced melanoma. congrats to j haanen and team!
#esmo2022 
Official Twitter account of the NCI Surgery Branch;
Adoptive Immunotherapy for Cancer;
Privacy:https://t.co/eoG1UirNdh